TheStreet.com  Apr 17  Comment 
NEW YORK (TheStreet) -- Shares of Novogen  rose 9.06% to $7.57 in afternoon trading Friday after the company announced it had signed a Memorandum of Understanding with the Feinstein Institute for Medical Research of New York to collaborate on...
TheStreet.com  Apr 9  Comment 
NEW YORK (TheStreet) -- Novagen shares spiked 24.72% to $5.62 in trading on Thursday after the Australia-based biotechnology company revealed that studies of its experimental drug, Anisina, showed signs of what could be a breakthrough in...
Benzinga  Apr 9  Comment 
Novogen Limited (NASDAQ: NVGN) jumped 47.23% to $6.64 on positive studies reported on Anisina ability to kill melanoma cells. Bio Blast Pharma Ltd. (NASDAQ: ORPN) shares rose 19.78% to $7.20 after the company announced a Fast Track Designation...
Benzinga  Apr 9  Comment 
US-Australian drug discovery company, Novogen (NVGN: NASDAQ) announced that studies conducted at The University of Queensland Diamantina Institute (UQDI) revealed that experimental drug, Anisina, killed melanoma cells irrespective of their...
The Australian  Apr 9  Comment 
Shares in drug manufacturer Novogen have soared after it reported a second successful cancer drug study in as many weeks.
Benzinga  Mar 30  Comment 
US-Australian drug discovery company, Novogen Ltd, (ASX:NRT; NASDAQ:NVGN) and its subsidiary, CanTx, Inc., and Yale University, on March 27 released pre-clinical data on experimental anti-cancer drug, Cantrixil. The data was presented as an oral...
The Australian  Mar 30  Comment 
Novogen’s share price has risen sharply after it said its experimental anti-cancer drug Cantrixil killed human ovarian stem cells.
Benzinga  Mar 18  Comment 
Novogen Limited (NASDAQ: NVGN) shares surged 45.78% to $4.49 in pre-market trading on positive Anisina report. Vitesse Semiconductor Corp. (NASDAQ: VTSS) gained 36.41% to $5.32 in pre-market trading after Microsemi Corp. (NASDAQ: MSCC)...
The Australian  Mar 18  Comment 
CANCER treatment developer Novogen says one of its drugs could help destroy a cancer cell’s “skeleton”.



Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki